In this study, we investigated a panel of CSF synaptic markers in presymptomatic and symptomatic people with genetic FTD from the GENetic Frontotemporal dementia Initiative (GENFI), hypothesizing that we would find differential abnormalities across MAPT, GRN, and C9orf72 mutation carriers. This evidence concerns the gene C9orf72 and frontotemporal dementia.